Skip to main content

FASCINATE-3 and FASCINIT Scalp Assessment

Baseline Analysis
6 months Analysis
12 months Analysis

Study Information​

FASCINATE-3​

  • Study Title: A phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of denifanstat in patients with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and F2/F3 fibrosis (FASCINATE-3)
  • Investigational Product: TVB-2640 (Denifanstat)

FASCINIT​

  • Study Title: A phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of denifanstat in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH) (FASCINIT)
  • Investigational Product: TVB-2640 (Denifanstat)

Version 1.0 - Version Date: 2025-02-18